Air Products and Chemicals, Inc. APD
Verdict: Sell. Fair value $250 against a price of $250 on 5 Jan 2026.
In plain words
The case for: Wide competitive moat provides durability. Market leadership enables pricing power. Industry tailwinds with growing market.
The case against: Net Income swung from $3.83B profit in 2024 to $-0.39B loss in 2025 despite flat revenue ($12.1B vs.... Revenue has declined/stagnated from $12.7B (2022) to $12.04B (2025), suggesting lack of organic.... 2024 Net Margin was 31.6% (vs historical ~18%), suggesting earnings were inflated by a significant....
Main risks
- Revenue Contraction: 3-year CAGR is negative (-1.8%) and 1-year growth is negative (-0.5%), indicating top-line stagnation.
- GAAP Profitability Collapse: FY2025 Net Income swung to a loss of $0.39B (Net Margin -3.2%) despite positive adjusted EPS, suggesting significant impairments or one-off charges.
- Data Opacity: Missing Balance Sheet data prevents assessment of leverage (Debt/Equity) and capital efficiency (ROIC/ROIIC).
- Net Income swung from $3.83B profit in 2024 to $-0.39B loss in 2025 despite flat revenue ($12.1B vs...
- Revenue has declined/stagnated from $12.7B (2022) to $12.04B (2025), suggesting lack of organic...
- Net Income swung from $3.83B profit in 2024 to $-0.39B loss in 2025 despite flat revenue ($12.1B vs $12.0B). Indicates massive non-recurring items.